In the GATA3–METH group, the majority of tumours belong to the basal-like molecular subtype (80.3%), 18.3% of tumours are HER2-enriched, only 1.4% of tumours are luminal-A, and no luminal-B tumours (Fig. 6C). Here, ERBB2 is linked to neoplasm.